Behavioral Activation to prevent and treat depression in older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a brief psychological treatment called Behavioral Activation (BA) for preventing and treating depression in older adults within a municipal context in Sweden. Participants aged 65 and older will be randomized to receive either the BA treatment, consisting of five sessions over two months, or continue with their usual care. The study aims to assess the impact of BA on various factors including depressive symptoms, anxiety, functional ability, and overall quality of life. Additionally, it will gather insights from both patients and therapists regarding their experiences with the treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 65 years or older
* 5 points or above on the Geriatric Depression Scale 15, GDS-15
* Fluent in written and spoken Swedish
* Consents to participate in the trial

Exclusion Criteria:

* Not able to use the patient materials due to visual impairment
* Not able to communicate with therapist due to hearing impairment
* Diagnosis of major neurocognitive disorder
* Below 25 points on the Mini Mental State Examination, MMSE
* Elevated suicide risk
* Current substance- or alcohol use disorder
* Previous or current psychotic disorder
* Previous or current bipolar disorder
* Ongoing psychological treatment/pscyhotherapy

Where it's running

• Eskilstuna kommun
  Eskilstuna, Sörmland, Sweden Recruiting

Study contacts

• Principal investigator: Johnny Pellas, PhD — Research and Development Sormland
• Study coordinator: Johnny Pellas, PhD
• Email: johnny.pellas@pubcare.uu.se
• Phone: +46702319795

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Metformin added to antidepressants for depression with obesity in Pakistani adults

  This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.

  Recruiting at 2 sites Riphah International University · Rawalpindi, Punjab Province and 1 other locations · NCT07654179

• Mindfulness‑augmented brain stimulation for treatment‑resistant depression

  This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.

  Recruiting Phase 2 University of California, San Diego · San Diego, California · NCT07512284

• Predicting depression in patients after heart surgery

  This study is trying to see if a new tool can help predict which patients might develop depression after heart surgery, so they can get help sooner.

  Recruiting University of Zurich · Zurich and 1 other locations · NCT06706323

• Mobile app for treating depression in cancer survivors

  This study tests if a mobile app called 'Moodivate' can help cancer survivors who are feeling depressed feel better over 12 weeks.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT06582784

• Oh Happy Day Class – Digital Connections for Depression in African Americans

  A mobile app delivers six weekly depression-therapy classes to African American adults to see if it helps reduce depressive symptoms.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT06206226

• Auricular acupuncture for treating depression during the Covid-19 pandemic

  This study is testing if auricular acupuncture can help university students with moderate depression feel better during the Covid-19 pandemic.

  Recruiting Universidade do Sul de Santa Catarina · Palhoça, Santa Catarina · NCT05855421

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.